You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T Cell Turnover

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022

Clinical and Biological Factors Determining Outcomes in Chronic

Recruiting
  • Chronic Graft vs Host Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (3 cycles chemo instead of 6 cycles chemo, 6 cycles

    Not yet recruiting
    • Ovarian Cancer
    • +3 more
    • 3 cycles chemotherapy instead of 6 cycles chemotherapy
    • 6 cycles chemotherapy
    • (no location specified)
    Jul 12, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Decitabine and Cedazuridine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 19, 2022

    Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

    Recruiting
    • Merkel Cell Carcinoma
    • Aurora, Colorado
    • +38 more
    Aug 3, 2022

    Job Stress, Burnout Trial in San Francisco (Enhanced Stress Resilience Training)

    Recruiting
    • Job Stress
    • Burnout
    • Enhanced Stress Resilience Training
    • San Francisco, California
      University of California, San Francisco
    Jun 6, 2023

    Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Pexastimogene Devacirepvec (Pexa-Vec)
    • Cemiplimab
    • Irvine, California
    • +17 more
    Oct 26, 2022

    Nuclear Cataract Trial in Rotterdam (Lens fragmentation)

    Not yet recruiting
    • Nuclear Cataract
    • Lens fragmentation
    • Rotterdam, Netherlands
      Oogziekenhuis Rotterdam
    Feb 9, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    Merkel Cell Carcinoma Trial in Worldwide (domatinostat in combination with avelumab)

    Active, not recruiting
    • Merkel Cell Carcinoma
    • domatinostat in combination with avelumab
    • Leuven, Belgium
    • +21 more
    Mar 16, 2022

    COVID-19 Trial in Saint Petersburg (Corfluvec component 1 low dose, Corfluvec component 2 low dose, Corfluvec component 1 high

    Active, not recruiting
    • COVID-19
    • Corfluvec component 1 low dose
    • +6 more
    • Saint Petersburg, Russian Federation
    • +1 more
    Jan 23, 2023

    Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

    Recruiting
    • Granuloma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

      Not yet recruiting
      • Angiosarcoma
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 23, 2023

      Iruplinalkib in Treatment of ALK-Positive Non-Small Cell Lung

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • Jinan, Shandong, China
        Shandong Cancer Hospital and Institute
      Aug 8, 2023

      Intracranial Germ Cell CNS Tumor, Childhood Trial in Beijing (radiation, drug, procedure)

      Recruiting
      • Intracranial Germ Cell CNS Tumor, Childhood
      • Whole-ventricle irradiation
      • +3 more
      • Beijing, China
        Beijing Tiantan Hospital
      Nov 7, 2021

      Multiple Sclerosis, Clinically Isolated Syndrome Trial in Worldwide (Ocrelizumab)

      Recruiting
      • Multiple Sclerosis
      • Clinically Isolated Syndrome
      • San Francisco, California
      • +9 more
      Aug 2, 2022

      NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

      Active, not recruiting
      • Non-Small Cell Lung Cancer
      • +12 more
      • Tucson, Arizona
      • +26 more
      Aug 1, 2022

      Hepatocellular Carcinoma Trial in Shanghai (Anlotinib Hydrochloride)

      Withdrawn
      • Hepatocellular Carcinoma
      • Anlotinib Hydrochloride
      • Shanghai, Shanghai, China
        Zhongshan Hospital, Fudan University
      Jun 23, 2021

      Diffuse Large B Cell Lymphoma Trial in France (ONCOLAXY Follow-up)

      Not yet recruiting
      • Diffuse Large B Cell Lymphoma
      • ONCOLAXY Follow-up
      • Bordeaux, France
      • +4 more
      Mar 25, 2022

      Diarrhea-predominant Irritable Bowel Syndrome With Anxiety and

      Enrolling by invitation
      • Irritable Bowel Syndrome With Diarrhea
      • Endoscopy
      • Xi'an, China
        Tang-Du Hospital
      Apr 2, 2022

      Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute

      Recruiting
      • Metastatic Melanoma
      • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      Hiv Trial (LP-98 injection)

      Not yet recruiting
      • Hiv
      • LP-98 injection
      • (no location specified)
      Jun 27, 2023

      COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)

      Recruiting
      • COVID-19
      • Umbilical cord mesenchymal stem cells implantation
      • Comparator
      • Shijiazhuang, Hebei, China
        The First Hospital of Hebei Medical University
      Feb 22, 2023

      Men With Low Testosterone Levels Trial in Culver City (Testosterone Enanthate, Placebo)

      Completed
      • Men With Low Testosterone Levels
      • Testosterone Enanthate
      • Placebo
      • Culver City, California
        Urological Sciences Research Foundation
      Apr 26, 2021

      Adenocarcinoma of Lung, Lung Cancer Trial in Minneapolis (Oral Restorative Microbiota Therapy (RMT) Capsules, Durvalumab 1500 mg

      Not yet recruiting
      • Adenocarcinoma of Lung
      • Lung Cancer
      • Oral Restorative Microbiota Therapy (RMT) Capsules
      • +3 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Apr 4, 2022